DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells

Genomics and Cancer Drug Resistance

(2012) Antonio S. Rodrigues et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Development of imatinib and dasatinib resistance: dynamics of expression of drug transportersABCB1, ABCC1, ABCG2, MVP, and SLC22A1

(2011) Marta Gromicho et al.   LEUKEMIA & LYMPHOMA

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) M. Baccarani et al.   ANNALS OF ONCOLOGY

Meta-analysis of microarray data: The case of imatinib resistance in chronic myelogenous leukemia

(2010) Francisco J. Burguillo et al.   COMPUTATIONAL BIOLOGY AND CHEMISTRY

Effects of base excision repair proteins on mutagenesis by 8-oxo-7,8-dihydroguanine (8-hydroxyguanine) paired with cytosine and adenine

(2010) Tetsuya Suzuki et al.   DNA REPAIR

Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia

(2010) D Bixby et al.   LEUKEMIA

The impact of gene profiling in chronic myeloid leukaemia

(2009) Agnes S.M. Yong et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Doxorubicin: The Good, the Bad and the Ugly Effect

(2009) Cristina Carvalho et al.   CURRENT MEDICINAL CHEMISTRY

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia

(2009) W. Deenik et al.   HAEMATOLOGICA

A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia

(2009) Hugues de Lavallade et al.   LEUKEMIA RESEARCH

Molecular biology of bcr-abl1-positive chronic myeloid leukemia

(2008) A. Quintas-Cardama et al.   BLOOD

The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells

(2008) David Guay et al.   CANCER SCIENCE

Statistical issues in the use of the comet assay

(2008) D. P. Lovell et al.   MUTAGENESIS

Therapy Options in Imatinib Failures

(2008) P. Ramirez et al.   ONCOLOGIST